Related Experiment Video

Updated: Aug 24, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Connective tissue growth factor and renal diseases: some answers, more questions

Nadia Abdel Wahab1, Roger M Mason

  • 1Cell and Molecular Biology Section, Division of Biomedical Sciences, Faculty of Medicine, Imperial College London, London, England, UK. nadia.wahab@imperial.ac.uk

Current Opinion in Nephrology and Hypertension
|April 20, 2004
PubMed
Abstract

Insights

Connective tissue growth factor (CCN2) is a key driver of kidney fibrosis by mediating transforming growth factor-beta effects. Understanding CCN2 mechanisms offers new therapeutic targets for renal disease.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Connective tissue growth factor (CCN2) is implicated in progressive renal fibrosis.
  • Mechanisms underlying CCN2's role in kidney disease remain largely unknown.

Purpose of the Study:

  • To review and discuss recent findings on the mechanisms of CCN2 in renal fibrosis.
  • To explore the relationship between CCN2 and transforming growth factor-beta (TGF-β).

Main Methods:

  • In-vitro studies of renal cells.
  • Review of emerging evidence on CCN2 and TGF-β interactions.

Main Results:

  • CCN2 mediates TGF-β-induced renal cell dysfunction, including hypertrophy and extracellular matrix deposition.
  • A strong interplay exists between CCN2 and TGF-β; TGF-β induces CCN2 expression, while CCN2 bioactivates latent TGF-β and promotes its signaling.
  • Recent evidence highlights CCN2's role in TGF-β bioactivation and Smad signaling.

Conclusions:

  • CCN2 is implicated in progressive renal disease pathogenesis.
  • Further research into CCN2 production, function, and signaling pathways is needed.
  • CCN2 represents a potential therapeutic target for combating renal fibrosis due to its link with TGF-β's properties.

More Related Videos

Intravascular Delivery of Biologics to the Rat Kidney07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...